Table 1 Clinical information of 75 lung adenocarcinoma and clusterin IHC intensity
From: Clusterin modulates transdifferentiation of non-small-cell lung cancer
Parameters | Number of cases | Clusterin IHC intensity | P-value |
|---|---|---|---|
Total case number | 75 | 1.0000 ± 0.0623 | |
Gender | |||
Male | 40 | 0.9880 ± 0.0888 | 0.8382 |
Female | 35 | 1.0140 ± 0.0881 | |
Age (yr) | |||
< =60 | 39 | 0.9640 ± 0.1013 | 0.6601 |
> 60 | 36 | 1.0210 ± 0.0779 | |
Tumor size (cm) | |||
< =3 | 37 | 1.0190 ± 0.0760 | 0.7610 |
> 3 | 38 | 0.9811 ± 0.0992 | |
Lymphnode status(n = 71) | |||
Positive | 36 | 0.8858 ± 0.0773 | 0.1553 |
Negative | 35 | 1.0700 ± 0.1016 | |
TNM stage (n = 75) | |||
I | 21 | 1.0380 ± 0.1056 | 0.5883 |
II | 39 | 0.9410 ± 0.0761 | |
III, IV | 15 | 1.0990 ± 0.1949 | |
Survival time (mon) | |||
< =40 | 40 | 1.0230 ± 0.0992 | 0.6917 |
> 40 | 35 | 0.9732 ± 0.0719 | |